Submitted by jhuang@research... on Wed, 11/09/2022 - 08:53
Emerging Role of Antibody-Drug Conjugates in the Management of Non-Small Cell Lung Cancer (Faculty Presentations)
Alexander I Spira, MD, PhD
CEO and Clinical Director, NEXT Virginia
Director, Virginia Cancer Specialists Research Program
Fairfax, Virginia
CEO and Clinical Director, NEXT Virginia
Director, Virginia Cancer Specialists Research Program
Fairfax, Virginia
Helena Yu, MD
Medical Oncologist
Associate Attending
Memorial Sloan Kettering Cancer Center
New York, New York